NEA Management Company’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
Other funds holding RARX
NEA Management Company's RARX Position: Q2 2020 in Review
NEA Management Company sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 6,138,797 shares — an estimated $295M sold.
NEA Management Company first reported a position in RARX in Q4 2016 and held it in 14 quarters. The position peaked at $295M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.
- NEA Management Company reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
- NEA Management Company sold 6,138,797 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $295M.
- NEA Management Company first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 14 quarters.
- NEA Management Company's Ra Pharmaceuticals, Inc. Common Stock position peaked at $295M in Q1 2020.
- 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.
Based on NEA Management Company's 13F filing for Q2 2020, filed 5 Aug 2020.